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Objective: In the United States, vascular surgeons frequently perform carotid endarterectomy (CEA). Given the resource
burden of unplanned readmission (URA), we sought to identify the predictors and consequences of URA after this
common vascular surgery procedure to identify potential points of intervention.
Methods: Using a prospective single-institution database, we retrospectively identiﬁed consecutive patients undergoing
CEA (2001-2011). Demographic and perioperative factors were prospectively collected. The primary end point was
30-day postdischarge URA after CEA. The secondary end point was 1-year survival. We performed a univariable analysis
for URA followed by a multivariable Cox model. A Kaplan-Meier analysis was performed for 1-year survival.
Results: During the study period, 840 patients underwent 897 CEAs. The 30-day postdischarge overall readmission rate
and URA rate were 8.6% and 6.5%, respectively. Most URA patients (n[ 42; 73.4%) were readmitted for a CEA-related
reason (headache, cardiac, hypertension, surgical site infection, bleeding/hematoma, stroke/transient ischemic attack,
dysphagia, or hyperperfusion syndrome). Seventeen patients (29.3%) had more than one reason for URA. Median time to
URA was 4 days (interquartile range, 1-9 days). Postoperative length of stay, indication for CEA, and discharge desti-
nation were not associated with URA. In multivariable analysis, in-hospital occurrence of congestive heart failure (hazard
ratio [HR], 15.1; 95% conﬁdence interval [CI], 4.7-48.8; P < .001), stroke (HR, 5.0; 95% CI, 1.8-14.0; P < .001),
bleeding/hematoma (HR, 3.1; 95% CI, 1.4-6.9; P[ .003), and prior coronary artery bypass grafting (HR, 2.0; 95% CI,
1.2-3.5; P[ .01) were signiﬁcantly associated with URA. Patients in the URA group also had decreased survival during
1 year (91% vs 96%; P [ .01, log-rank).
Conclusions: The 30-day URA rate after CEA is low (6.5%). Prior coronary artery bypass grafting and in-hospital
postoperative occurrence of stroke, bleeding/hematoma, and congestive heart failure identify those at increased risk of
URA, and URA signals increased long-term risk of postoperative mortality. (J Vasc Surg 2014;60:77-84.)Outcomes evaluation is integral to deﬁning the cost-
effectiveness of surgical procedures. One outcome that
has gained traction as a measure of quality of care and
health care resource utilization is hospital readmission
within 30 days. Our objective was to precisely estimate
the 30-day readmission rate after carotid endarterectomy
(CEA), one of the procedures most frequently performed
by vascular surgeons in the United States,1 to understand
the factors that contribute to early unplanned readmission
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Data source. This is an Institutional Review Boarde
approved, single-center cohort study of patients undergoing
CEA between November 29, 2001, and June 29, 2011.
Demographics, comorbidity, intraoperative, and outcome
data were captured prospectively in an institutional registry.
All combined procedures, including combined coronary
artery bypass grafting (CABG)-CEA procedures, were
excluded.
Perioperative details. All CEAs were performed by
attending vascular surgeons under general anesthesia with
routine electroencephalographic (EEG) monitoring. Pa-
tients were given acetylsalicylic acid (81 mg or 325 mg)
by mouth up to and including the morning of surgery.
Endarterectomies were performed in a standard fashion
with patch angioplasty closure. Shunting was performed
selectively. Protamine was given at the end of the case at
the discretion of the surgeon.
Variables and end points. The primary end point was
URA, deﬁned as any unanticipated, nonelective hospital
readmission within 30 days of date of discharge after
CEA. The secondary end point was 1-year survival. A
CEA-related reason for readmission was deﬁned as any
medical or surgical complication that occurred as a sequela
of surgery2; perforated colon cancer is an example of an77
Table I. Baseline characteristics
Baseline characteristic No. (%)
Median age, years (IQR) 70.1 (64-77)
Female gender 349 (39.0)
White 850 (95.0)
Past medical history
Diabetes 271 (30.3)
Smoking 246 (27.5)
HTN 736 (82.2)
CAD 390 (43.6)
CHF 58 (6.5)
Prior CABG 179 (20.1)
COPD 89 (9.9)
CKD (serum Cr > 2.0 mg/dL) 37 (4.1)
ESRD 3 (0.3)
Indication
Asymptomatic 586 (65.4)
TIA 122 (13.6)
Recent stroke 95 (10.6)
Amaurosis fugax 92 (10.3)
Contralateral occlusion 58 (6.5)
Reoperative CEA 22 (2.5)
Preadmit 102 (11.4)
CABG, Coronary artery bypass graft; CAD, coronary artery disease; CEA,
carotid endarterectomy; CHF, congestive heart failure; CKD, chronic kid-
ney disease; COPD, chronic obstructive pulmonary disease; Cr, creatinine;
ESRD, end-stage renal disease; HTN, hypertension; IQR, interquartile
range; TIA, transient ischemic attack.
Table II. Frequency of in-hospital morbidity after CEA
In-hospital morbidity No. (%)
At least 1 in-hospital complication 89 (9.9)
2 or more in-hospital complications 25 (2.8)
In-hospital complications
TIA 6 (0.7)
Stroke 9 (1.0)
Bleeding/hematoma 37 (4.1)
Arrhythmia 19 (2.1)
Seizure 2 (0.2)
MI 11 (1.2)
PNA 9 (1.0)
Respiratory failure 7 (0.8)
Renal failure 7 (0.8)
CHF 4 (0.5)
Wound infection 9 (1.0)
Pulmonary embolism 1 (0.1)
Carotid thrombosis 2 (0.2)
Dysphagia 15 (1.7)
Reoperation 27 (3.0)
CEA, Carotid endarterectomy; CHF, congestive heart failure; MI,
myocardial infarction; PNA, pneumonia; TIA, transient ischemic attack.
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tions were deﬁned as hematoma, surgical site infection,
wound dehiscence, or neurologic event (intracerebral
hemorrhage, seizure, transient ischemic attack [TIA], or
stroke). A medical complication was deﬁned as any medical
condition that occurred as a sequela of CEA. These con-
ditions were broadly grouped into cardiac (eg, congestive
heart failure [CHF], myocardial infarction [MI], arrhythmia,
or angina pectoris), headache, hypertension (systolic blood
pressure >140 mm Hg), and “other medical problems,”
including respiratory or pulmonary issues, renal insufﬁ-
ciency, and gastrointestinal problems.
Statistical analysis. We performed a univariate analysis
for URA with two-tailed Student t-tests for continuous
variables (Mann-Whitney U tests for nonparametric
continuous variables) and c2 tests for categorical variables
(Fisher exact tests for nonparametric categorical variables),
followed by a multivariable Cox model with variables that
were statistically signiﬁcant at the P < .05 level on uni-
variable analysis. The Cochran-Armitage trend test was
used to assess for a trend in the annual rate of URA. The
Kaplan-Meier method was used to estimate 1-year survival
data.
RESULTS
During the study period, 840 patients underwent 897
CEA procedures by 10 vascular surgery attending sur-
geons. Baseline characteristics are reported in Table I.
Median age was 70.1 years (interquartile range [IQR],
64-77 years); 142 patients (15.8%) were octogenarians
and eight (0.9%) were nonagenarians. In 102 cases
(11.4%), patients were admitted before the day of CEA
(“preadmitted”), whereas the rest were admitted on the
day of surgery. Median follow-up was 3.4 years (IQR,
1.2-5.2 years).
Most cases were performed under general anesthesia
(99.1%) with EEG monitoring (94.3%). One hundred
four patients (12.2%) had EEG changes. One hundred
sixty-three patients (18.2%) had intraoperative shunts.
Drains were placed in 236 (26.4%) cases. Median operating
room time was 2.8 hours (IQR, 2.3-3.3 hours).
One hundred twenty-four patients (13.9%) required
transfer to the intensive care unit postoperatively, usually
in the setting of hypotension (n ¼ 69; 55.6%) or hyperten-
sion (n ¼ 38; 30.6%). Median and mean postoperative
length of stay (LOS) were 1 day (IQR, 1-2 days) and
2.4 6 4.4 days, respectively. The range was 1 to 66 days.
Most patients (n ¼ 837; 93.7%) were discharged to
home; of these, 312 (34.9%) were discharged with visiting
nurse services. Fifty-eight (6.5%) had a 30-day postdi-
scharge URA. There was no association between LOS
and URA (6.0% vs 7.0%; P ¼ .59).
As shown in Table II, 9.9% of patients (n ¼ 89) suf-
fered at least one in-hospital complication and 2.8% (n ¼
25) suffered two or more in-hospital complications.
Among patients who had a complication, mean and median
number of complications was 1.3 6 0.7 and 1 (IQR, 1-2),
respectively. The most frequent complication was bleedingor hematoma, which occurred in 4.1% (n ¼ 37) of cases.
Three percent (n ¼ 27) of patients required reoperation,
usually for a bleeding complication (n ¼ 24; 88.9%). There
were 15 postoperative strokes (1.7%), six of which occurred
after initial discharge, two of which were disabling, and
none of which was fatal. Cause of death was known in three
of the ﬁve patients who died within 30 days of CEA
(ruptured thoracoabdominal aortic aneurysm, Clostridium
Fig 1. Frequency of reasons for unplanned readmission (URA) after carotid endarterectomy (CEA). TIA, Transient
ischemic attack.
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death rate and 1-year death rate were 2.2% and 3.5%,
respectively. There were nine patients (1.0%) who did not
return for follow-up after discharge within 30 days or by
1 year postoperatively.
Seventy-seven patients (8.6%) were readmitted to our
institution within 30 days of discharge after index CEA.
Of these, 58 (75.3%) readmissions were unplanned,
yielding an overall URA rate of 6.5%. There was no trend
in annual rate of URA during the period studied (P ¼
.11). All planned readmissions were for elective surgery,
including lower extremity revascularization, parotidec-
tomy, mitral valve replacement, hysterectomy, distal
pancreatectomy, contralateral CEA, subclavian artery
revascularization, and liver resection. Median time to
URA was 4 days (IQR, 1-9 days). More than three quarters
(77.6%) of URAs occurred within the ﬁrst 10 days after
discharge.
The distribution of reasons for URA is shown in Fig 1.
The most frequent reason for readmission was cardiac, fol-
lowed by headache, bleeding/hematoma, neurologic event
(stroke/TIA/intracerebral hemorrhage), and “other med-
ical reason” (examples include anemia, nausea or vomiting
from narcotics, dehydration, mechanical fall, pulmonary
embolism, C. difﬁcile colitis, pneumonia, and hypoglyce-
mia). Seventeen patients (29.3%) had more than one
reason for URA. In most cases (n ¼ 42; 73.4%), the
URA was related to CEA. Seven patients (12%) had a
URA unrelated to CEA within 30 days (for the following
reasons: ruptured thoracoabdominal aneurysm, mechanical
falls, diverticular bleed, hypoglycemia, and ischemic
bowel). Three patients were readmitted between 31 and
60 days after surgery and three were readmitted more
than 60 days after surgery for a CEA-related reason. Thesethree patients were readmitted for a carotid restenosis,
vocal cord medialization for presumed cranial nerve injury
during CEA, and latent patch infection.
Seventeen patients (29.3%) in the URA group had at
least one additional hospital readmission during 1 year in
comparison to 179 patients (21.3%) in the non-URA group.
The results of univariable analysis of factors associated
with URA are shown in Table III. Patients requiring
URA were more likely to have comorbidities of CHF
(13.8% vs 6.0%; P ¼ .02) or prior CABG (34.5% vs
19.1%; P ¼ .005) and to have had postoperative in-
hospital stroke (6.9% vs 1.0%; P < .001), bleeding/hema-
toma (12.1% vs 3.6%; P ¼ .002), MI (5.2% vs 1.0%;
P ¼ .005), CHF (5.2% vs 0.1%; P < .001), or reoperation
(8.6% vs 2.6%; P ¼ .01). Preoperative symptom state, pre-
admission status, and discharge destination after index hos-
pitalization had no impact on readmission (P ¼ .09, .55,
and .89, respectively). There was no signiﬁcant difference
in the index postoperative LOS between patients with
and without a URA (median [IQR], 1.5 [1-2] vs 1
[1-2]; P ¼ .54).
In the multivariable analysis, in-hospital occurrence of
CHF (hazard ratio [HR], 15.1; 95% conﬁdence interval
[CI], 4.7-48.8; P < .001), stroke (HR, 5.0; 95% CI,
1.8-14.0; P < .001), bleeding/hematoma (HR, 3.1; 95%
CI, 1.4-6.9; P ¼ .003), and prior CABG (HR, 2.0; 95%
CI, 1.2-3.5; P ¼ 01) were predictors of URA (Table IV).
Patients in the URA group had decreased survival during
1 year, as shown in Fig 2 (91% vs 96%; P ¼ .01, log-rank).
DISCUSSION
In this large, contemporary study, the 30-day same-
institution URA rate for CEA was 6.5%. Not surprisingly,
the most common reasons for URA were related to the
Table III. Univariable analysis of factors associated with unplanned readmission (URA)
Total cohort
(N ¼ 897)
No URA
(n ¼ 837) (93.5%)
URA
(n ¼ 58) (6.5%) P valuea
Median age, years (IQR) 69.3 (64-76) 71 (64-77) 71 (64-77) .95
Female gender 349 (39.1) 326 (39.0) 23 (39.7) .92
Nonwhite 45 (5.0) 40 (4.8) 5 (8.6) .20
Diabetes mellitus 271 (30.3) 248 (29.6) 23 (40.0) .11
Current smoker 245 (27.4) 232 (27.7) 14 (24.1) .55
Hypertension 735 (82.3) 688 (82.2) 48 (82.8) .91
Prior CABG 179 (20.0) 160 (19.1) 20 (34.5) .005
CHF 57 (6.4) 50 (6.0) 8 (13.8) .02
COPD 89 (10.0) 80 (9.6) 9 (15.5) .14
CKD (serum Cr $ 2.0 mg/dL) 37 (4.1) 32 (3.9) 5 (8.6) .08
Dialysis 3 (0.3) 3 (0.4) 0 1.0
Symptomatic carotid stenosis 309 (34.6) 283 (33.8) 26 (44.8) .09
Surgeon with low CEA volume (<18/y) 402 (45.0) 375 (44.8) 28 (48.3) .61
Preadmit status 102 (11.4) 94 (11.2) 8 (13.8) .55
Operating room start time after 12:00 PM 243 (27.2) 226 (27.0) 17 (29.3) .72
Median operating room time, hours (IQR) 2.8 (2.3-3.3) 2.7 (2.3-3.3) 2.9 (2.4-3.5) .14
EEG changes 104 (12.1) 95 (11.9) 9 (16.1) .36
Shunt 163 (18.4) 152 (18.2) 11 (19.0) .98
Drain 236 (26.4) 218 (26.1) 18 (31.0) .41
Postoperative Foley catheter 132 (14.8) 121 (14.5) 11 (19.3) .32
Postoperative ICU 124 (13.9) 113 (13.5) 11 (19.0) .24
Postoperative HTN requiring continuous medication infusion 38 (4.3) 34 (4.1) 4 (6.9) .30
Postoperative hypotension requiring continuous
medication infusion
69 (7.7) 65 (7.8) 4 (6.9) .94
Discharge to facility 56 (6.3) 54 (6.5) 4 (6.9) .89
Mean ICU LOS (if in ICU postoperatively) 6 SD (range) 2.4 6 3.2 (0-32) 2.4 6 3.3 (0-32) 1.7 6 0.9 (0-3) .54
Median postoperative LOS, days (IQR) 1 (1-2) 1 (1-2) 1.5 (1-2) .54
Median total LOS, days (IQR) 3 (2-4) 2 (2-4) 3 (2-4) .16
At least 1 in-hospital postoperative morbidity 89 (10.0) 74 (8.8) 15 (25.9) <.001
Mean number of complications 6 SD (range) 0.15 6 0.5 (0-4) 0.13 6 0.5 (0-4) 0.34 6 0.7 (0-3) <.0001
Postoperative TIA 6 (0.7) 6 (0.7) 0 .53
Postoperative stroke 12 (1.3) 8 (1.0) 4 (6.9) <.001
Postoperative bleeding/hematoma 37 (4.1) 30 (3.6) 7 (12.1) .002
Postoperative arrhythmia 19 (2.1) 19 (2.3) 0 .25
Postoperative MI 11 (1.2) 8 (1.0) 3 (5.2) .005
Postoperative PNA 9 (1.0) 8 (1.0) 1 (1.7) .57
Postoperative respiratory failure 7 (0.8) 7 (0.8) 0 .76
Postoperative renal failure 7 (0.8) 6 (0.7) 1 (1.7) .40
Postoperative CHF 4 (0.5) 1 (0.1) 3 (5.2) <.001
Postoperative surgical site infection 9 (1.0) 7 (0.8) 2 (3.5) .11
Early carotid thrombosis 2 (0.2) 2 (0.2) 0 1.0
Postoperative dysphagia 15 (1.7) 13 (1.6) 2 (3.5) .35
Reoperation 27 (3.0) 22 (2.6) 5 (8.6) .01
CABG, Coronary artery bypass graft; CEA, carotid endarterectomy; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive
pulmonary disease; Cr, creatinine; EEG, electroencephalography; HTN, hypertension; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay;
MI, myocardial infarction; PNA, pneumonia; SD, standard deviation; TIA, transient ischemic attack.
Categorical variables are presented as number (%).
aBold values indicate P <.05.
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currences of hematoma, stroke, or CHF exacerbation
were independent predictors of URA.
Under the Affordable Care Act, Congress enacted
the Hospital Readmissions Reduction Program, through
which the Centers for Medicare and Medicaid Service
(CMS) penalizes hospitals for higher-than-expected
rates of risk-adjusted readmissions after acute MI, pneu-
monia, and heart failure beginning in ﬁscal year 2013.3
CMS has proposed to expand the applicable conditions
for ﬁscal year 2015 to include patients admitted for an
acute exacerbation of chronic obstructive pulmonarydisease and patients admitted for elective total hip
arthroplasty and total knee arthroplasty.3 Patients
admitted for vascular procedures may also be added in
the near future.4
We found a low URA rate of 6.5% after CEA. The
overall readmission rate (planned or unplanned) was
8.6%, and there was no signiﬁcant change in the rate of
URA during the entire study period. Previously reported
30-day readmission rates after CEA range from 0% to
9.2%.5-11 The largest of these studies6 was a retrospective
evaluation of 7019 CEAs at multiple centers between
1990 and 1995. Readmission rates at included centers
Table IV. Predictors of URA by multivariable analysis
Variable HR 95% CI P
In-hospital postoperative CHF
exacerbation
15.1 4.7-48.8 <.001
In-hospital postoperative stroke 5.0 1.8-14.0 <.001
In-hospital postoperative hematoma 3.1 1.4-6.9 .003
Prior CABG 2.0 1.2-3.5 .01
CABG, Coronary artery bypass graft; CHF, congestive heart failure; CI,
conﬁdence interval; HR, hazard ratio; URA, unplanned readmission.
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tween planned readmission and URA was made, and there
was no analysis of factors contributing to readmission,
which limits the degree to which these results are action-
able. More recently, Cikrit et al5 observed a 4% 30-day
readmission rate in a 200-patient cohort from the Veterans
Administration medical system, and Hupp et al7 reported
an 8.8% readmission rate from the Medicare Provider and
Analysis Review 2005-2009 database. Finally, our analysis
of the 2011 National Surgical Quality Improvement Pro-
gram (NSQIP) database (7195 CEAs) revealed a 7.1%
URA rate (unpublished).
Our observed overall perioperative complication rate of
9.9% is within the range reported in the literature. In the
surgery arm of the North American Symptomatic Carotid
Endarterectomy Trial (NASCET), there was an 8.1% rate
of perioperative medical complications12; in combination
with perioperative nonfatal strokes and death, the overall
perioperative complication rate was 14.6%.13 In the New
York Carotid Artery Study of 9308 CEAs performed at
167 centers, the perioperative complication rate (including
nonfatal stroke, death, and minor surgical complications)
was 13.9%.14 In the Carotid Revascularization Endarterec-
tomy vs Stenting Trial (CREST), the overall perioperative
complication rate in the surgical arm was 13.3%.15 At the
other end of the spectrum, LaMuraglia et al16 reported a
5.5% overall 30-day complication rate (including stroke/
death, cranial nerve injury, TIA, bleeding, cardiac, pulmo-
nary, infectious, hyperperfusion, renal failure, and miscella-
neous events) in a retrospective single-center analysis of
2236 CEAs.
Prior literature demonstrated that the majority of peri-
operative strokes occur within 6 hours of surgery (eg, NAS-
CET trial13) because many of these events are related to
technical issues of the endarterectomy site, but there is
recent evidence that postdischarge events are also com-
mon. Half of the postdischarge neurologic events we
observed were related to cerebral hyperperfusion. In
2008, Goodney et al17 reported that after 3092 CEAs per-
formed at 11 hospitals, 5 of 52 strokes (10%) occurred after
discharge but within 30 days of surgery. Kang et al18
looked at 3949 CEAs in the 2005-2006 NSQIP database
and found that 23 of 62 strokes (37%) occurred after
discharge, with the mean total LOS of 2.7 6 4.2 days.
Finally, in 2013, Fokkema et al19 reported that according
to the 2005-2010 NSQIP database, 195 of 591perioperative strokes (33%) occurred after discharge in a to-
tal data set of 35,916 CEA patients. Taken together, these
data suggest that a signiﬁcant proportion of events occur
after discharge after CEA, which is consistent with our
ﬁnding that 6 of 15 strokes occurred after discharge.
Any postoperative complication has been implicated as
a strong independent predictor of URA after general sur-
gery20 and carotid procedures21 alike, and we observed a
similar relationship in our study. Of the postoperative in-
hospital complications we examined (TIA, stroke, seizure,
hematoma, dysphagia, respiratory failure, wound infection,
arrhythmia, MI, renal failure, and reoperation), only stroke,
hematoma, or CHF exacerbation were signiﬁcantly associ-
ated with URA.
The association between URA and CHF is consistent
with prior observations that cardiac risk factors (including
chronic obstructive pulmonary disease and history of
CHF) are associated with LOS after major vascular sur-
gery22 and that CHF is associated with increased in-
hospital mortality after carotid revascularization.23 It is
possible that our URA rate may be underestimated or over-
estimated because of our institution’s rate of CHF. How-
ever, our hospital’s adjusted 30-day readmission rate for
heart failure (24.7%) at the time of this report is no
different from the national rate of readmission.24
Prior CABG conferred two times the hazard of URA
compared with patients who did not have prior CABG.
When the time of prior CABG was dichotomized into
recent (within 6 months of CEA) and remote (6 months
before CEA or earlier), the correlation with URA was
observed only in the remote CABG group, suggesting
that the risk for URA stemmed from progression of coro-
nary disease or of coronary risk factors in patients who
had undergone CABG.
As regards the negative correlation between URA and
survival, further research is needed to identify preventable
causes of death and to determine whether mortality is
related to carotid disease or a procedure-related complica-
tion. However, it is likely that the overall burden of comor-
bid disease in these patients, rather than the readmission
event itself, is associated with mortality.
The use of URA as a quality measure is controversial.
Researchers at the Cleveland Clinic used Medicare data
to demonstrate that hospitals with higher readmission rates
had lower 30-day mortality rates.25 Similarly, the Greater
New York Hospital Association, using data from the
CMS’s public website, Hospital Compare, demonstrated
that mortality is inversely related to readmissions and that
states with lowest percentile rankings for morality had the
highest adjusted 30-day readmission rates, and vice versa.26
Unlike administrative databases, our dataset had
detailed clinical information that had been prospectively
collected for research purposes rather than for billing pur-
poses. We collected data on readmissions 30 days after
discharge rather than after the procedure (as in the Amer-
ican College of Surgeons NSQIP database) such that
there is no bias toward patients who had a shorter postop-
erative LOS.
Fig 2. Decreased survival during 1 year among patients with 30-day unplanned readmission (URA). Log-rank c2, 6.0;
P ¼ .01.
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retrospective nature. We were unable to reliably capture
readmissions to other hospitals, and hence we included
only readmissions to our institution. We traditionally treat
post-CEA patients with headache and hypertension aggres-
sively and have a low threshold to readmit them for obser-
vation and management, which may have increased our
rate of URA in comparison to other centers. Finally, we
did not capture sociodemographic and other health care
history variables that are potential factors inﬂuencing read-
mission. These include poverty, low English or health liter-
acy, recent admissions, frequent emergency department
visits, depression, a home medication list of six or more
medications, discharge on a weekend or holiday weekend,
lack of understanding of postdischarge plan of care, and
delayed or inadequate communication with the next pro-
vider of direct care.27
CONCLUSIONS
In the setting of this study, the 30-day URA rate after
CEA is low (6.5%), but a URA signals increased long-term
risk of postoperative mortality. Vascular surgeons across
the country should continue to strive toward a zero-event
rate with regard to URA. Prior CABG and in-hospital post-
operative occurrence of stroke, bleeding/hematoma, and
CHF identify those at increased risk of URA. These risk fac-
tors may represent modiﬁable areas to further reduce URA
after CEA.
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Submitted Sep 24, 2013; accepted Jan 21, 2014.DISCUSSIONDr John Ricotta (Washington, D.C.). Do you have any data
on your perioperative anticoagulation protocol? Do you think
you’re sending your patients home too quickly? Your average
length of stay is 1 day and perhaps this affects your readmission
rate.
Dr Karen J. Ho. This cohort includes the patients of 10 sur-
geons, and virtually all of them give protamine at the end of the
case. Our rate of bleeding complications has decreased over the
10-year study period, possibly because of the initiation of prot-
amine. I think the higher rate of hematoma and bleeding that
we report partially reﬂects the period of time before we were using
protamine regularly.
Dr Ricotta. I just wonder whether maybe the pendulum has
gone a little too far in one direction. Why don’t you answer that
question and then we’ll get Dr Moore.
Dr Ho. The mean postoperative length of stay of this cohort
was 2.4 days with a range of 1 to 66 days. Using this same patient
cohort, we know that increased length of stay is not associated with
decreasing unplanned readmissions.
Dr Wesley Moore (Los Angeles, Calif). I have just one ques-
tion. I noted that you were only capturing readmission to your
own hospital. In my institution, I have patients coming from a
fair distance away, and I suspect that must be true in your institu-
tion as well when you’re looking at the experience in a tertiary care
medical center. I’m wondering if you’re missing readmissions to
other hospitals, and would it be possible to go back and ﬁnd out
that information as well?
DrHo. That’s a very good point. It’s one of the weaknesses of
a single-center cohort study. Our rate of unplanned readmission is
6.5%. The unplanned readmission rate from a VA study that was
published in 2004 was 4%. The readmission rate from the 2011
NSQIP database, which includes readmission data for the ﬁrst
time, is approximately 7%. And a paper that was presented at theMidwestern Vascular Society last year reported an unplanned read-
mission rate of 8.8% in a Medicare database. So I think even
though we are not capturing readmissions that perhaps went to
another hospital, our readmission rate is still comparable to
contemporary estimates.
We could potentially go back to the charts and see if there are
any mentions of readmissions to other centers, but my gut feeling
is that patients tend to want to be seen by their surgeon for any
problems that occur in the ﬁrst month postop.
Dr Marat Goldenberg (Cartersville, Ga). Have you looked
at the difﬁculty in stabilizing blood pressure postoperatively within
the ﬁrst 24 hours and correlate that with an appearance of compli-
cation or problems whether they result in admissions or not? And if
blood pressure was difﬁcult to control, either high or low, should
the patient be kept in the hospital for an extra day?
Dr Ho. It’s our routine practice to be very aggressive about
maintaining systolic blood pressure between 100 and 140 mm
Hg. We typically do not discharge patients until their blood pres-
sure is stable within these parameters on an oral medication
regimen. A third of our patients went home with a visiting nurse
and usually that’s for either wound checks or for blood pressure
checks. We also have a care coordinator who calls patients post
discharge day 1 to check on those issues.
Dr Krishnasamy Soundararajan (Wilmington, Del). I was
interested in the group which was admitted for headache. It is
generally believed that the chances of reperfusion symptoms are
higher in patients with contralateral occlusion or high-grade steno-
sis. Would you be able to elaborate if you had looked into or if it is
worth looking into the status of the contralateral carotid perfusion
in those patients with headache?
Dr Ho. The reason why we are very aggressive about readmit-
ting patients with headache and not discharging patients who
report a headache is that we are concerned about cerebral
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sion and the incidence of headache.
Dr Matthew Sweet (Seattle, Wash). In light of the discus-
sion about the beneﬁt of carotid endarterectomy in asymptomatic
patients, can you infer anything about the patients who had post-
operative CHF in terms of helping to better risk stratify patients
before the operation? Have these data changed the practice
pattern at your hospital, or are there any other lessons we can
take away on who maybe shouldn’t have an asymptomatic carotid
endarterectomy?Dr Ho. I think we all know that the rate of readmission for
patients with CHF is very high. Nationally the average readmis-
sion rate is on the order of 20% to 24%. I looked up our hospital’s
readmission rate for CHF patients and it matches the national
average.
I think that once one has determined that a patient is at risk
for a postop complication but potentially could also beneﬁt from
the surgery, I think one has to accept that there is a risk/beneﬁt
ratio to everything one does, understand the factors that contribute
to risk, and try to minimize them to the best of one’s ability.
